| #132 |
Vikrant Verma |
IBM |
2 |
| #132 |
Bharathi Pandi |
Avista Pharma Solutions |
2 |
| #132 |
Eric Torr Espenhahn |
Physcient |
2 |
| #132 |
Jiwei Fan |
Texas Instruments |
2 |
| #132 |
Rohit Singh |
Netapp |
2 |
| #132 |
Stephen J. Kenna |
IBM |
2 |
| #132 |
Mark E. Molander |
IBM |
2 |
| #132 |
Wayne D. Dettloff |
Rambus |
2 |
| #132 |
F. Scott Moody |
K4Connect |
2 |
| #132 |
An Zhang |
Biogen Ma |
2 |
| #132 |
Jun Chen |
Synopsys |
2 |
| #132 |
Lisa M. Bradley |
— |
2 |
| #132 |
Dianne B. Ellis |
Avintiv Specialty Materials |
2 |
| #132 |
Geri D. McGrath |
IBM |
2 |
| #132 |
Qingchun Zhang |
Cree |
2 |
| #132 |
Seyedalireza Yektamaram |
Sas Institute |
2 |
| #132 |
Allen W. Hanson |
Macom Technology Solutions Holdings |
2 |
| #132 |
Owen Lewis Joyce |
Rai Strategic Holdings |
2 |
| #132 |
Asiri Ediriwickrema |
Yale University |
2 |
| #132 |
David Burns |
IBM |
2 |
| #132 |
Brian Christopher Attwood |
Thermochem Recovery International |
2 |
| #132 |
Ronald J. Pettis |
Becton, Dickinson And |
2 |
| #132 |
Manmohan Singh |
Glaxosmithkline Biologicals Sa |
2 |
| #132 |
Yenchin Liao |
Opus Medical Therapies |
2 |
| #132 |
Albert A. Chung |
IBM |
2 |
| #132 |
Sorabh Murgai |
IBM |
2 |
| #132 |
Ajoy Velayudhan |
Bristol-Myers Squibb |
2 |
| #132 |
Alfred C. Lindem, III |
Cisco |
2 |
| #132 |
William Yang |
Biogen Ma |
2 |
| #132 |
Christopher L. Larson |
Arysta Lifescience |
2 |
| #132 |
Jun Liu |
Siemens Aktiengesellschaft |
2 |
| #132 |
Al Safarikas |
Ideal Industries Lighting |
2 |
| #132 |
Kai Tan |
Netapp |
2 |
| #132 |
Gurdas S. Sandhu |
3Datx |
2 |
| #132 |
M. Jason Houston |
Intersil Americas |
2 |
| #132 |
Haseeb Niazi |
Cisco |
2 |
| #132 |
Aamer Akhter |
Cisco |
2 |
| #132 |
Jeremy Nevins |
Cree |
2 |
| #132 |
Keith Gausmann |
The Procter & Gamble |
2 |
| #132 |
Jerzy Michal Brzezicki |
Sas Institute |
2 |
| #132 |
Srikanth N. Rao |
Cloudflare |
2 |
| #132 |
Garrett M. Drapala |
IBM |
2 |
| #132 |
Ramakrishna Sista |
Advanced Liquid Logic |
2 |
| #132 |
Deepak Gowda |
Emc Ip Holding Company |
2 |
| #132 |
Bryan D. Osenbach |
IBM |
2 |
| #132 |
Dipak Tailor |
— |
2 |
| #132 |
Jaysun Giesler |
— |
2 |
| #132 |
Erkang Zheng |
Fmr |
2 |
| #132 |
James Redpath |
Akzo N.V. |
2 |
| #132 |
Scott Kelso |
— |
2 |